Clinical Trials Directory

Trials / Sponsors / Mirror Biologics, Inc.

Mirror Biologics, Inc.

Industry · 15 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnCombined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Phase 22026-11-01
SuspendedImmunotherapy for Advanced Liver Cancer
Hepatocellular Carcinoma
Phase 2 / Phase 32023-08-01
CompletedUniversal Anti-Viral Vaccine for Healthy Elderly Adults
Virus Diseases, Pneumonia, COVID-19 Respiratory Infection
Phase 1 / Phase 22021-07-12
CompletedImmunotherapy for Third Line Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Phase 22021-07-12
WithdrawnAlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Phase 2 / Phase 32017-12-01
WithdrawnStudy Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck
Squamous Cell Carcinoma Head and Neck
Phase 22016-12-01
CompletedAlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer
Colorectal Cancer Metastatic
Phase 22016-09-01
CompletedAn Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects
Advanced Adult Hepatocellular Carcinoma
Phase 22016-07-01
CompletedSafety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and N
Cancer of Head and Neck, Squamous Cell Carcinoma of the Head and Neck
Phase 22016-01-01
WithdrawnIn-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer
Hepatocellular Carcinoma
Phase 1 / Phase 22014-11-01
WithdrawnIncreased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patien
Metastatic Breast Cancer
Phase 1 / Phase 22014-03-01
WithdrawnAn Individualized Anti-Cancer Vaccine Study in Patients With HCC
Hepatocellular Carcinoma
Phase 1 / Phase 22013-12-01
CompletedA Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy
Hematological Malignancy, Leukemia, Lymphoma
Phase 1 / Phase 22010-12-01
TerminatedBioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers
Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma
Phase 1 / Phase 22010-01-01
CompletedIn-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation
Metastatic Cancer
Phase 1 / Phase 22009-08-01